Rebion
PrivateLast Round
Grant
Apr 6, 2022
Total Funding Raised
$3.94M
Company Overview
Rebion is a diagnostic equipment company that has developed a neural performance scanning platform to detect and monitor brain diseases and injuries such as amblyopia (lazy eye) and traumatic brain injury (TBI).
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rebion Comparables
Compare Rebion with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GoCheck Kids | 83% | |
| Plusoptix | 79% | |
| RightEye | 78% |
Rebion Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 6, 2022 | ||||
| Grant | May 4, 2020 | ||||
| Series A | Oct 1, 2019 | ||||
| Grant | Sep 1, 2016 | ||||
| Grant | Aug 1, 2015 |
Rebion Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Neurological Disorders and Stroke | Grant |
| National Eye Institute | Grant |
| Loudoun County Economic Development Authority | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 6, 2022
$1M grant from the National Institute of Neurological Disorders and Stroke.
- May 4, 2020
$25K grant from Loudoun County Economic Development Authority.
Rebion Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rebion's valuation, stock price, and market status.
Is Rebion a public or private company?
Rebion is a private company.
What is the current stock price of Rebion?
Rebion is a private company with no public stock price. No recent secondary market data is available.
How much is Rebion worth (valuation)?
Valuation information for Rebion is not publicly available.
Can I buy Rebion stock?
Rebion shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Rebion's last funding round?
Rebion's most recent funding round was Grant on April 6, 2022.
Who are the main investors in Rebion?
Key investors in Rebion include National Institute of Neurological Disorders and Stroke, National Eye Institute, Loudoun County Economic Development Authority.
Will Rebion IPO soon?
No public IPO plans have been announced for Rebion.
How can I track Rebion secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rebion's secondary market activity and sign up for updates.